March 24, 2020 Price forecast | 2 weeks: 3.44% | 1 month: 2.90% | 3 months: 10.12% | Premium Forecast


NTGN stock forecast

Our latest prediction for BioNTech US, Inc.'s stock price was made on the March 24, 2020 when the stock price was at 2.23$.

In the short term (2weeks), NTGN's stock price should outperform the market by 3.44%. During that period the price should oscillate between -13.87% and +22.33%.

In the medium term (3months), NTGN's stock price should outperform the market by 10.12%. During that period the price should oscillate between -39.40% and +56.10%.

Create a solid portfolio with NTGN

Add NTGN to your portfolio and optimize it!


About BioNTech US, Inc.

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.86$ per share.

The book value per share is 4.92$

BioNTech US, Inc. website


Three months stock forecastMarch 24, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -81M - -80M -2.86 - - 28M 4.92 -73M -1M -74M